| Serial Number | 90042373 |
| Word Mark | DXT |
| Filing Date | Wednesday, July 8, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, September 5, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 15, 2020 |
| Goods and Services | downloadable computer software for use in identifying new drugs; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data for use in making informed medical decisions; downloadable virtual reality software for medical teaching; downloadable virtual reality software for medical screening; downloadable computer software platforms for use in database management in the field of medicine; downloadable computer application software for mobile phones, namely, software for use in identifying new drugs; downloadable computer software using artificial intelligence for use in identifying new drugs; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems |
| Goods and Services | Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceutical preparations; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of rare ocular disorders or diseases; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold preparations; pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of rare tissue and organ transplantation-related diseases and conditions; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations, namely, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; disinfectants for hygiene purposes; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations, namely, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; disinfectants for hygiene purposes; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems |
| Goods and Services | software as a service (SAAS) services featuring software using artificial intelligence for use in identifying new drugs; providing a website featuring non-downloadable software using artificial intelligence for use in identifying new drugs; research in the field of artificial intelligence; design and development of computer software in the field of medicine; design and development of virtual reality software for medical screening; design and development of virtual reality software for medical teaching |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 6, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 6, 2020 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 6, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DOMPÉ FARMACEUTICI SPA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Milano 20122 IT |
| Party Name | DOMPÉ FARMACEUTICI SPA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Milano 20122 IT |
| Event Date | Event Description |
| Tuesday, September 6, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, September 5, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, February 4, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 2, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, February 2, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, February 2, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, August 3, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, June 24, 2021 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Thursday, June 3, 2021 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Wednesday, June 2, 2021 | ASSIGNED TO PETITION STAFF |
| Tuesday, May 25, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 25, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 29, 2021 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Friday, January 8, 2021 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, December 15, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 15, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 25, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, November 9, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, November 7, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 6, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 6, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 20, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 20, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 20, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, October 16, 2020 | ASSIGNED TO EXAMINER |
| Thursday, August 6, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, July 11, 2020 | NEW APPLICATION ENTERED IN TRAM |